Advanced search
Publication Cover
Infection and Drug Resistance Volume 13, 2020 - Issue
Submit an article Journal homepage
314
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality

Yulin Zhang1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Yi Li2 Department of Laboratory Medicine, Henan Provincial People’s Hospital, Zhengzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-5849-6040
ORCID Icon,
Ji Zeng3 Department of Laboratory Medicine, Wuhan Pu Ai Hospital of Huazhong University of Science and Technology, Wuhan, People’s Republic of China
,
Yanzi Chang4 Department of Laboratory Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, People’s Republic of China
,
Shouhua Han5 Department of Laboratory Medicine, Weifang No.2 People’s Hospital, Weifang, People’s Republic of China
,
Jiankang Zhao1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Yanyan Fan1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5931-5427
ORCID Icon,
Zhujia Xiong1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2274-4986
ORCID Icon,
Xiaohui Zou1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Chunlei Wang1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Binbin Li1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Haibo Li1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Jiajing Han1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Xinmeng Liu1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Yudi Xia1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China
,
Binghuai Lu1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-3510-2747
ORCID Icon &
Bin Cao1 Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing100029, People’s Republic of China;6 Clinical Center for Pulmonary Infections, Capital Medical University, Beijing, People’s Republic of China;7 Tsinghua University-Peking University, Joint Center for Life Sciences, Beijing, People’s Republic of China
 show all
Pages 4115-4123 | Published online: 12 Nov 2020

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xianzhen Wei, Linlin Li, Meng Li, Hongjie Liang, Yu He & Shan Li. (2023) Risk Factors and Outcomes of Patients with Carbapenem-Resistant Pseudomonas aeruginosa Bloodstream Infection. Infection and Drug Resistance 16, pages 337-346.
Read now
Jie Qin, Chengyun Zou, Jianmin Tao, Tian Wei, Li Yan, Yufei Zhang & Haiying Wang. (2022) Carbapenem Resistant Pseudomonas aeruginosa Infections in Elderly Patients: Antimicrobial Resistance Profiles, Risk Factors and Impact on Clinical Outcomes. Infection and Drug Resistance 15, pages 2301-2314.
Read now
Chaoe Zhou, Longyang Jin, Qi Wang, Xiaojuan Wang, Fengning Chen, Yue Gao, Chunjiang Zhao, Hongbin Chen, Bin Cao & Hui Wang. (2021) Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales: Risk Factors for Mortality, Antimicrobial Therapy and Treatment Outcomes from a Prospective Multicenter Study. Infection and Drug Resistance 14, pages 731-742.
Read now

Articles from other publishers (11)

Li Ding, Yue Sun, Yizhuo Zhang, Siquan Shen & Fupin Hu. (2023) In Vivo Development of Aztreonam Resistance in Meropenem-Resistant Pseudomonas aeruginosa Owing to Overexpression of the bla PDC-16 . Microbiology Spectrum 11:3.
Crossref
Jim Abi Frem, George Doumat, Jamil Kazma, Amal Gharamti, Souha S. Kanj, Antoine G. Abou Fayad, Ghassan M. Matar & Zeina A. Kanafani. (2023) Clinical predictors of mortality in patients with pseudomonas aeruginosa infection. PLOS ONE 18:4, pages e0282276.
Crossref
Yu. E. Skurikhina, E. K. Papynov, E. A. Zaitseva & O. O. Shichalin. (2023) Bacterial biofilm formation on ceramics of various composition used for orthopedic endoprosthetics. Pacific Medical Journal:1, pages 50-54.
Crossref
Ming-Ying Ai, Huai-En Lu, Wan-Yu Lee, Hsin-Yi Liu, Han-Chuan Chuang, Bi-Li Chen, Er-Ying Wang, Li-Hsin Tsao & Yuarn-Jang Lee. (2023) Development of a combination antibiogram for empirical treatments of Pseudomonas aeruginosa at a university-affiliated teaching hospital. Journal of Microbiology, Immunology and Infection 56:2, pages 344-350.
Crossref
Aryaan Khan, Ahmed El Hosseiny & Rania Siam. (2023) Assessing and Reassessing the Association of Comorbidities and Coinfections in COVID-19 Patients. Cureus.
Crossref
Payam Behzadi, Márió Gajdács, Péter Pallós, Boglárka Ónodi, Anette Stájer, Danica Matusovits, Krisztina Kárpáti, Katalin Burián, Basem Battah, Marco Ferrari, Carlo Doria, Gianfilippo Caggiari, Ameer Khusro, Stefania Zanetti & Matthew Gavino Donadu. (2022) Relationship between Biofilm-Formation, Phenotypic Virulence Factors and Antibiotic Resistance in Environmental Pseudomonas aeruginosa. Pathogens 11:9, pages 1015.
Crossref
Swetha Ramanathan, Fritzie S Albarillo, Margaret A Fitzpatrick, Katie J Suda, Linda Poggensee, Amanda Vivo, Martin E Evans, Makoto Jones, Nasia Safdar, Chris Pfeiffer, Bridget Smith, Geneva Wilson & Charlesnika T Evans. (2022) Infectious Disease Consults of Pseudomonas aeruginosa Bloodstream Infection and Impact on Health Outcomes . Open Forum Infectious Diseases 9:9.
Crossref
Mohammad Reza Rahbar, Shaden M. H. Mubarak, Anahita Hessami, Bahman Khalesi, Navid Pourzardosht, Saeed Khalili, Kobra Ahmadi Zanoos & Abolfazl Jahangiri. (2022) A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa. Scientific Reports 12:1.
Crossref
Compaoré Eli, Ouédraogo Vincent, Compaoré Moussa, Rouamba Ablassé & Kiendrebeogo Martin. (2022) Anti-quorum sensing potential of Ageratum conyzoides L. (Asteraceae) extracts from Burkina Faso. Journal of Medicinal Plants Research 16:5, pages 174-187.
Crossref
Márió Gajdács, Zoltán Baráth, Krisztina Kárpáti, Dóra Szabó, Donatella Usai, Stefania Zanetti & Matthew Gavino Donadu. (2021) No Correlation between Biofilm Formation, Virulence Factors, and Antibiotic Resistance in Pseudomonas aeruginosa: Results from a Laboratory-Based In Vitro Study. Antibiotics 10:9, pages 1134.
Crossref
Payam Behzadi, Zoltán Baráth & Márió Gajdács. (2021) It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics 10:1, pages 42.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.